Zeno J. Frediani | People | Arnold & Porter

Zeno Frediani advises clients on UK and EU competition law in relation to merger control, cartels and restrictive practices, abuse of dominance, and private damages claims. He also advises clients on the UK’s investment screening powers for national security matters. He has extensive experience in providing pragmatic commercial solutions to complex regulatory issues. Zeno advises world-leading organisations, particularly within the FMCG and pharmaceutical sectors. He has also assisted clients in CMA and European Commission investigations.

In relation to antitrust litigation, Zeno has experience handling competition damages litigation in various jurisdictions, including England & Wales and The Netherlands.

He maintains an active pro bono practice and regularly advises charities and NGOs on a wide range of legal and strategic matters.

Focus Areas

Experience

Touchlight Genetics in obtaining foreign investment clearances in relation to an agreement with Ceva Animal Health to use Touchlight’s dbDNA technology in animal health.
Novo Nordisk on European and other international antitrust and regulatory approvals in connection with its US$11 billion acquisition of three fill-finish sites from Novo Holdings A/S (Novo Holdings). As part of the deal, valued at US$16.5 billion, Novo Holdings acquires (through a merger) Catalent, Inc., a NYSE listed CDMO headquartered in New Jersey.
Boston Scientific in its $615 million acquisition of Apollo Endosurgery.
Pfizer in its $43 billion acquisition of Seagen Inc., a world-leader in antibody-drug conjugates (ADCs).
Lifeworks, in obtaining all competition and foreign direct investment clearances outside of Canada related to its C$2.9 billion sale to TELUS.

Bristol-Myers Squibb in its $4.1 billion acquisition of Turning Point Therapeutics.
Pfizer in obtaining merger control clearances in relation its $6.7 billion acquisition of Arena Pharmaceuticals.
Wheels Up Experience Inc. in obtaining foreign investment clearances in relation to its proposed acquisition of Air Partner plc.
Boston Scientific in relation to its $1.07 billion acquisition of Lumenis before multiple competition authorities worldwide.
Skyscanner in relation to its £1.4 billion acquisition by Ctrip.

Heineken, Diageo, AB InBev and Morrisons in relation to damages claims in the Netherlands and England & Wales arising out of the EU trucks cartel.
Global pharmaceutical company in relation to a follow-on competition damages action in the English High Court related to a decision by the European Commission.
Global pharmaceutical company in relation to investigations by the CMA and the European Commission into patent settlement agreements.
Global online retailer in relation to the CMA's investigation into anti-competitive agreements in the light fittings sector.

Pharmaceutical manufacturer in managing parallel trade and supply quotas.
Global pharmaceutical company on the competition law compliance of establishing agency arrangements for its EU-wide sales.
Five global travel companies in relation to the competition law compliance of industry collaboration and joint procurement.
Global pharmaceutical company in relation to the competition law compliance of distribution and pricing arrangements.
Government department in relation to the State aid compliance of a multi-million pound investment into a proposed telecommunications project.

Four children and their mother in securing the regularized immigration status of a family that fled Nigeria for the UK. This was a collaboration with Kids in Need of Defense UK (KIND), the preeminent non-governmental organization devoted to legal protection of unaccompanied children in immigration proceedings.
A father in the inquest into the deaths of his 23-month-old twins at the hands of their mother.
An individual in an appeal before the First Tier Tribunal challenging a decision of the Department for Work and Pensions not to award certain disability benefits.